JPS5794660A - Measurement of inhibitor-enzyme compound - Google Patents

Measurement of inhibitor-enzyme compound

Info

Publication number
JPS5794660A
JPS5794660A JP56154047A JP15404781A JPS5794660A JP S5794660 A JPS5794660 A JP S5794660A JP 56154047 A JP56154047 A JP 56154047A JP 15404781 A JP15404781 A JP 15404781A JP S5794660 A JPS5794660 A JP S5794660A
Authority
JP
Japan
Prior art keywords
enzyme
inhibitor
enzyme inhibitor
antibody
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56154047A
Other languages
English (en)
Other versions
JPH041304B2 (ja
Inventor
Kaanaasu Haaperu Piitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of JPS5794660A publication Critical patent/JPS5794660A/ja
Publication of JPH041304B2 publication Critical patent/JPH041304B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP56154047A 1980-09-30 1981-09-30 Measurement of inhibitor-enzyme compound Granted JPS5794660A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19216680A 1980-09-30 1980-09-30

Publications (2)

Publication Number Publication Date
JPS5794660A true JPS5794660A (en) 1982-06-12
JPH041304B2 JPH041304B2 (ja) 1992-01-10

Family

ID=22708529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56154047A Granted JPS5794660A (en) 1980-09-30 1981-09-30 Measurement of inhibitor-enzyme compound

Country Status (5)

Country Link
EP (1) EP0048989B1 (ja)
JP (1) JPS5794660A (ja)
AT (1) ATE15387T1 (ja)
CA (1) CA1176560A (ja)
DE (1) DE3172143D1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6134465A (ja) * 1984-07-26 1986-02-18 Teijin Ltd ヒトα↓２−プラスミンインヒビタ−に対するモノクロ−ナル抗体を用いた免疫学的測定試薬及びキツト
JPS6488368A (en) * 1987-09-30 1989-04-03 Shigeru Hayashi Method for measuring complex of urokinase and urokinase inhibitor
JP2016511394A (ja) * 2013-01-20 2016-04-14 ダイアックス コーポレーション ｐＫａｌ関連疾病の評価、アッセイおよび治療
US11754570B2 (en) 2019-04-16 2023-09-12 Takeda Pharmaceutical Company Limited Methods for quantitation of functional C1 esterase inhibitor (FC1-INH)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080279B1 (en) * 1981-11-02 1986-02-05 James Walter Ryan Method for assaying proteases with tagged proteinaceous inhibitors
US4499186A (en) * 1982-12-30 1985-02-12 University Of Illinois, Board Of Trustees Diagnosing autoimmune rheumatoid arthritis by measuring proteolytic activity of α2 -macroglobulin
DE3531778A1 (de) * 1985-09-06 1987-03-12 Behringwerke Ag Verfahren zur bestimmung von proteaseinhibitoren
GB9119102D0 (en) * 1991-09-07 1991-10-23 Biosyn Ltd Bioimmunassay
GB9312638D0 (en) * 1993-06-18 1993-08-04 Hafslund Nycomed As Assay
NL9301134A (nl) * 1993-06-29 1995-01-16 Inst Voor Agrotech Onderzoek Werkwijze voor het detekteren en eventueel kwantificeren van aktiviteit van ten minste één protease-inhibitor in een te analyseren mengsel, alsmede toepassing van de werkwijze voor het bepalen van de (rest)aktiviteit van één (of meer) afzonderlijke (iso)type(s) protease-inhibitor(en) en toepassing van de werkwijze voor het bepalen van de totale (rest)aktiviteit van een mengsel eventueel na een verwerkingsproces zoals een proces ter verwijdering of inaktivatie van protease-inhibitor(en).
FI100557B (fi) * 1994-08-26 1997-12-31 Ulf-Haakan Stenman Vapaan trypsinogeeni-2:n määritys
EP0759556A3 (de) * 1995-07-24 1998-05-20 BEHRINGWERKE Aktiengesellschaft Verfahren zur Quantifizierung aktivierter Faktoren
WO2005017138A2 (en) * 2003-08-19 2005-02-24 Novozymes A/S Active-site titration of glycosyl hydrolases

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5530692A (en) * 1978-08-17 1980-03-04 Behringwerke Ag Method of immunological measuring
JPS5646465A (en) * 1979-09-25 1981-04-27 Seikagaku Kogyo Co Ltd Measuring method for man pancreas secretory inhibiter in humor
JPS56118671A (en) * 1980-02-22 1981-09-17 Amano Pharmaceut Co Ltd Measuring method of specific enzyme immunity of hybrid type protein
JPS57551A (en) * 1980-04-30 1982-01-05 Merck Patent Gmbh Immunologic measuring method and means of enzyme

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7602422A (nl) * 1976-03-08 1977-09-12 Leuven Res & Dev Vzw Trombosetest.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5530692A (en) * 1978-08-17 1980-03-04 Behringwerke Ag Method of immunological measuring
JPS5646465A (en) * 1979-09-25 1981-04-27 Seikagaku Kogyo Co Ltd Measuring method for man pancreas secretory inhibiter in humor
JPS56118671A (en) * 1980-02-22 1981-09-17 Amano Pharmaceut Co Ltd Measuring method of specific enzyme immunity of hybrid type protein
JPS57551A (en) * 1980-04-30 1982-01-05 Merck Patent Gmbh Immunologic measuring method and means of enzyme

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6134465A (ja) * 1984-07-26 1986-02-18 Teijin Ltd ヒトα↓２−プラスミンインヒビタ−に対するモノクロ−ナル抗体を用いた免疫学的測定試薬及びキツト
JPH0441783B2 (ja) * 1984-07-26 1992-07-09 Teijin Ltd
JPS6488368A (en) * 1987-09-30 1989-04-03 Shigeru Hayashi Method for measuring complex of urokinase and urokinase inhibitor
JP2016511394A (ja) * 2013-01-20 2016-04-14 ダイアックス コーポレーション ｐＫａｌ関連疾病の評価、アッセイおよび治療
US10690670B2 (en) 2013-01-20 2020-06-23 Dyax Corp. Assays for determining levels of plasma protease C1 inhibitor
US11892450B2 (en) 2013-01-20 2024-02-06 Takeda Pharmaceutical Company Limited Evaluation, assays and treatment of pKal-mediated disorders
US11754570B2 (en) 2019-04-16 2023-09-12 Takeda Pharmaceutical Company Limited Methods for quantitation of functional C1 esterase inhibitor (FC1-INH)

Also Published As

Publication number Publication date
JPH041304B2 (ja) 1992-01-10
ATE15387T1 (de) 1985-09-15
EP0048989A2 (en) 1982-04-07
DE3172143D1 (en) 1985-10-10
EP0048989B1 (en) 1985-09-04
CA1176560A (en) 1984-10-23
EP0048989A3 (en) 1982-05-12

Similar Documents

Publication Publication Date Title
JPS5794660A (en) Measurement of inhibitor-enzyme compound
ATE386934T1 (de) Methode und vorrichtung zum nachweis oder zur quantifizierung von kohlenhydrate enthaltenden verbindungen
ATE26487T1 (de) Einrichtung zur feststellung und zahlenmaessigen auswertung von agglutinaten.
DE69412137D1 (de) Sensoreinrichtung zum sandwichtest
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
ATE201771T1 (de) Spezifische bindungstests und reagenzien dafür
ATE267399T1 (de) Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)
EP0279097A3 (en) Immunoassay test strip
ATE12010T1 (de) Verfahren zur bestimmung von antigen-antikoerper- reaktionen und reagens hierfuer.
PT97839A (pt) Processo para a deteccao e/ou doseamento de hormonas e anticorpos utilizaveis no referido processo de deteccao
AU641399B2 (en) Method for determining nucleic acid
DK328584A (da) Immunobestemmelsesmetode for en iodthyronin i en biologisk vaeske samt reagenssystem, testsaet og testmateriale til anvendelse ved metoden
DE59308966D1 (de) Mittel zur Bestimmung eines Analyts
DE3850346D1 (de) Verfahren zur Selbstdurchführung von Enzymkinetik.
DE69529691D1 (de) Differenziertes timingsverfahren zum nachweiss multiple analyte in eine testprobe
EP0176246A3 (en) Method and kit for detecting the presence of gum disease
ES8706966A1 (es) Metodo de ensayar muestras de fluido en cuanto a la presencia de anticuerpos contra un microorganismo y dispositivo correspondiente
DE3171892D1 (en) Method for detection of oncofetal antigen, for detection of cancer, for evaluation for cancer therapy and diagnostic kit suitable for such purpose
NO920624L (no) Reagens for paavisning av fibrinolytisk aktivitet
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
ATE107031T1 (de) Verfahren zur bestimmung eines liganden.
EP0124103A3 (en) Fluorometric assay of chymopapain and reagents therefor
ES2056191T3 (es) Un metodo para la deteccion de una substancia de union especifica en la sangre y kit de ensayo para llevar a cabo dicho metodo.
DE3485740D1 (de) Immunologisches testverfahren eines prokoagulierenden enzyms zum nachweis von krebs.
ATE117727T1 (de) Verfahren zur bestimmung von isoenzymen.